chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Localize rash to back of neck along hairline, around neck, and face. Pt report minor swelling, itching, radiating heat secondary to adverse reaction. Pt's skin appeared inflamed.
t100.8 R, crying x 3-5hr, loss of appetite, tremors in lower extremities;unable to console;
Patient came in to the pharmacy on 08/22/2021 and wanted to let us know that since she received the vaccine on 08/08/201 she had a rash on left arm that got wider and spread to cover the top of her arm, she had been taking Benadryl and the swelling and rash had gone down and it was not hard to the touch or hot. She stated she will keep on taking Benadryl until rash is completely gone.
VACCINE GIVEN POST EXPIRATION; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, and batch number: 1805029 expiry: 25-MAY-2021) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-MAY-2021, the subject experienced vaccine given post expiration. The action taken with covid-19 vaccine  was not applicable. The outcome of vaccine given post expiration was not reported. This report was non-serious.
I've had abnormal Vaginal bleeding. My period is not due for another two weeks. I track my cycle and have tracked my cycle for the last three years never once have I had vaginal bleeding apart from my menses which is always a regular at 28 to 29 days.
Severe Headache, Fever, Weakness, Aches, Rapid Heartbeat, Burning eyes, Dehydration. Received IV fluids and medication at North Shore Medidal Ctr, Salem, MA
11cmx4cm area of erythema and swelling on thigh around injection site. Appearance most compatible with reaction to one vaccine componets. Tx with ice and Keflex. x 7 days.
9 days after the vaccine, I woke up with a large red rash on my right arm around the area where the injection occurred.  I did not go to the doctor's about it, having read that it can happen with the Moderna shot.  96 hours after the appearance of the rash, it is still present.  It is fading (not as bright red) but the area covered is expanding.    The area feels warm to the touch and itches on occasion.  It is not raised and is flush with the rest of the arm.
Pt received injection of Tetanus and Diphtheria Toxoids Adsorbed, Ultrafined on 10/16/1999.  On 10/18/1999, the pt developed jaw pain and stiffness and was seen in the physicians office.  On 10/22/91999 the jaw pain subsided slightly, however, the right side of the patients jaw remained stiff.
no adverse events the only issue is vaccine given at a not recommended age, patient age at the time 17 yrs old and vaccine age recommended at 18 yrs old.
This spontaneous report as received from a registered pharmacist refers to a 61 year old male patient. The patient's relevant medical history, relevant concomitant medications and past drug history were unknown. On 09-SEP-2013 the patient was vaccinated with ZOSTAVAX (lot # J003359, expiry date 21-JUN-2014, dose and frequency were unknown). Other suspect therapies included influenza virus vaccine (unspecified)(manufacturer unknown). On 09-SEP-2013, the patient returned to the pharmacy this evening, with a rash all over the left side of his body, from head to toe. He received his ZOSTAVAX vaccine in the left arm. It unknown where the flu "shot" was given. It was unknown if there was any relevant laboratory data. As of 09-SEP-2013, the patient no longer took the ZOSTAVAX; it was unknown if the patient would continue to receive the flu "shot" and he continued to experience the rash all over the left side of his body, from head to toe. Additional information has been requested.
Increased Tinnitus and whooshing in ears Hearing Loss Nausea Migraine headaches
Patient is experiencing redness and soreness in the arm where she got the ZOSTAVAX injection. She has not checked with a doctor about this but has a regular appointment soon and will discuss then. Patient declined to be transferred to submit report. This spontaneous report as received from a consumer refers to a female patient of unknown age. The patient was vaccinated with ZOSTAVAX. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced redness of the arm where ZOSTAVAX was injected and soreness at injection site. No treatment information was reported. The outcome of redness of the arm where ZOSTAVAX was injected and soreness at injection site is unknown. The relatedness for redness of the arm where ZOSTAVAX was injected is unknown for ZOSTAVAX. Additional information is not expected.
Did not return to receive the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 8th May 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient received first Shingrix dose, however did not return within the recommended time frame to receive the second dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient did not receive the 1st dose of Shingrix at the pharmacy, so lot number, expiration date, and site of injection was unknown. The reporter consented to follow up. This case has been linked to US2021216652, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021216652:Same reporter.
Case number PHEH2014US014956 is an initial spontaneous report from the pharmacist received on 25 Jul 2014. This report refers to a 33 year old male patient. On 07 Jul 2014, the patient was inadvertently vaccinated with Men A lyophilized component of MENVEO (batch number: A13066) reconstituted with sodium chloride solution instead of Men CYW-135 liquid component. No adverse event reported following this medication error (wrong solution used in drug reconstitution).
Pain in right side of neck,nausea, No treatment, went away within 45 mins
Information has been received from a healthcare worker concerning unspecified number of patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On unknown dates of 2016, the patients were vaccinated with improperly stored doses of ZOSTAVAX (lot # M001746, expiration date: 07-APR-2017) (dose, frequency and route were not reported) for prophylaxis. It was reported that the vaccines were exposed to a temperature of 8 Fahrenheit degree during a time frame of 1 hour and 30 minutes. Previous temperature excursion was 25 Fahrenheit degree during a time frame of 1 hour. After the initial excursion and not the current excursion, the patients had administered the vaccine. Data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA004450: US-009507513-1701USA004451.
Symptoms of itching and warm area around injection site started Saturday 9/28. From there, the area around injection site started enlarging in size and became increasingly itchy, red and hot. Patient took BENADRYL and gabapentin for symptoms. By 10/1, symptoms improved and area is decreasing in size and redness.
5 days after vaccination, arm began swelling, redness, itching spreading down to elbow. Has bone pain. Increase in wheezing. Decreased blood pressure. Slight tachycardia.
firing in my body; my heart pounding really hard/ my heart is pounding to my chest; tingling in my blood and body; my blood my body its like flowing through me/ rush like in my blood; I am in state of confusion; hard to breath; nervousness also came along; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 24Mar2021 as dose 1, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. On 24Mar2021, after vaccination the patient was fine for 2-3 min after about 3-4 minutes then patient got like this rush like in blood and there was like firing in entire body and patient heart was pound really hard. The patient has to stay there after the shot. The patient did not feel the shot which was fine and was perfect for about 2-3-4 minutes. After that while walking patient start having like a tingling in blood and body, it was the blood but patient guess the whole body is felt like flowing through me and then patient heart is like pounding to chest. The patient was in a state of confusion then like hard to breath for that minute or 2 and then patient have to put the arm down to pull the chair that was there. Patient just help down to sat on the chair and it is just the heart was still breathing. Its going better with time but patient wait there for like for at least 30-40 minutes. It was still then when the patient was leaving for harvest store, kind of going hard. The patient was nervousness also came along with it but patient was in a state of confusion for like yesterday. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
passed out after receiving first vaccine; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer (patient) reported that a male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient passed out after receiving first vaccine on an unspecified date. The outcome of the event was unknown. The event was considered as serious (medically signficant).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Tingling in the feet; Tremor in hands; Cramping in her legs; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in the feet), TREMOR (Tremor in hands) and MUSCLE SPASMS (Cramping in her legs) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008621-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced PARAESTHESIA (Tingling in the feet), TREMOR (Tremor in hands) and MUSCLE SPASMS (Cramping in her legs). At the time of the report, PARAESTHESIA (Tingling in the feet), TREMOR (Tremor in hands) and MUSCLE SPASMS (Cramping in her legs) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medications are provided. treatment to the events not reported. patient want to know if she can received the second dose as scheduled  despite the ongoing symptoms on 24-apr-2021.
Swelling, itching and inflammation of injection site/arm lessened with antihistamine (zyrtec 10mg OD) ? aka ?COViD-arm?
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs, drug reactions and allergies was not provided. On an unknown date, the patient was vaccinated with an improperly stored ROTATEQ 2 milliliter, once, orally, lot # R021216, expiration date 25-APR-2020 (reported as "25-MAY-2020) for prophylaxis. The vaccine was exposed to a highest temperature above 47°F (50°F) for 2 hours. There was a previous temperature excursion, where the lowest temperature was below 36°F/2°C (33.4°F) for 12 hours, and the highest temperature was above 47°F/9°C (50°F) for 12 hours. It was reported that digital data logger was involved. No adverse effects were reported.This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1903USA006841.
01/04/2011 12:45 PM: Visited OBGYN for 12 week pregnancy check up.  Heard baby's heartbeat.  All was good and healthy.  Instructed by Nurse Practioner to get flu shot.  01/04/2011 6:30pm I received the FLUZONE 2010-11 Vial .5ml.  On 01/05/2011 10:00 AM I had a standard ultrasound test and there was no heartbeat.  On 01/07/2011 I had a D and C.  As of 01/26/2011 the uterus is still bleeding.  An ultrasound was performed on 01/24/2011  at 1:40 PM and it was determined that there is blood, blood clots and remaining tissue.  A second D and C is scheduled for tomorrow 01/27/2011 at 2 PM.
local rxn & tender, egg sized lump;hot to touch in axilla w/in 8-10hr of vax;
Pt inadvertently recvd DT instead of TD; Devel swollen arm & fever of 102;
No adverse effects were reported.; Patient was "administered a dose of Havrix and then inadvertently administered a dose VAQTA too soon.''; This spontaneous report has been received from a nurse referring to a 75 years old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reaction/allergies were not reported.   On 21-MAY-2019, the patient was vaccinated with a dose of hepatitis a virus vaccine inactivated (HAVRIX) (lot# 299X2, expiration date 24-JAN-2022; dose number and route were unknown). On 08-JUL-2019, the patient was inadvertently vaccinated with a dose of hepatitis a vaccine, inactivated (VAQTA) (lot # S001832, expiration date 12-MAY-2020; dose number and route was unknown) for prophylaxis (inappropriate schedule of vaccine administered). No adverse effects were reported. The outcome of the events was unknown. No product quality complaint presented.
Patient began crying and acting as if really bad stomach ache and passing lots of gas, then ears started swelling, trunk area turned red, then eyes and lips swoll and whole body turned red and a fast heart beat  Vaccine was the Aventis U1143AA type
fully vaccinated + booster listed above- pfizer for all 3 doses developed worsened cough 1/7/2022 and tested positive for covid on abbott id now rapid molecular test
Pt reports to clinic for f/u appointment with provider. Reports to RN and this nurse that the area where she got vaccine is swollen, warm to touch and hurts. Area is swollen upon inspection, measures 55 cm wide, pt denies any fever. Pt evaluated by provider, advise on BENADRYL and cold compress and to D/C vaccine series. Per nurse provider to consult for further management.
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment details were reported.   This case was linked to MOD-2021-392458 (Patient Link).
the adverse event its a error on administration. Patient comes to the clinic for his 3th dose (1st booster) but patient was injected with the monovalent moderna vaccine instead of the bivalent moderna vaccine (0.25 ml administered), the administered vaccine was past of the date of use by 3 days (expiration date: 11/22/22), no temperature excursion for this vaccine. We are waiting responses of the immunization system and from the manufacture (moderna) to see how proceed with the patient, if we need to revaccinate the patient(s) or what else we can do.
Starting the morning after the injection experienced gastric upset and loose bowels and general malaise. Loose stools have subsided but still feeling very tired and having gastric cramping.
Information has been received from a nurse concerning an 11 year old 75 lb male with a sulfa allergy who on 06-JUL-2007 was vaccinated with his second dose of varicella virus vaccine live (Oka/Merck) (lot.no 657650/0716U) and Menactra in the R arm and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid in the L deltoid. At the time of the vaccination, the patient had contact dermatitis described as an itchy rash on his trunk and extremities. He was treated with fluocinolone, cool compress, Benadryl, bacitracin and Calamine. On 09-JUL-2007, the patient was seen in follow up of the poison ivy on his face, ear, left finger and arm, R hand, back and under R arm. He also had a 1 1/2 inch circle of induration, redness and some slight tenderness 1 1/2 inches below the varicella injection site of his R arm, which occurred on 08-JUL-2007. The patient's poison ivy and injection site induration, redness and tenderness persisted (in follow up, the outcome was reported as unknown). He was prescribed oral prednisone for the contact dermatitis but it was discontinued on 12-JUL-2007 due to behavioral side effects. Additional information is not expected.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 64 year old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 26-SEP-2014, the patient was vaccinated at a Military Clinic/Hospital with a dose of zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a health care professional for the herpes zoster. The outcome of the event was not reported. The reporter considered the herpes zoster to be related to zoster vaccine live (ZOSTAVAX).
Pt felt tightness in the back of head and warm feeling in chest. Denied shortness of breath, itching, swelling. Pt did not have a reaction with first dose. History of anxiety. Brought to medical observation, symptoms resolved after 10 minutes.
itchiness on the left leg; swelling on the left leg; Initial information received on 03-Dec-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves eight years old female patient who experienced itchiness on the left leg (vaccination site pruritus) and swelling on the left leg (vaccination site swelling), while she received vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 27-Nov-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED lot UJ237AB, Exp. Date 30-Jun-2020 via unknown route in the left vastus lateralis.  On 27-Nov-2019, the patient developed a non-serious itchiness on the left leg (vaccination site pruritus) and swelling on the left leg (vaccination site swelling) at night following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED.  Final diagnosis was vaccination site pruritus and vaccination site swelling.   It was not reported if the patient received a corrective treatment.  The outcome was unknown for vaccination site pruritus and vaccination site swelling.
He is COVID positive here.throat swelling, fever, and diarrhea.  He has had fever intermittently since last week.
This spontaneous report as received from a nurse concerning 5 patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On unknown dates, the patients were vaccinated with PNEUMOVAX 23 (dosing details, route, anatomical location were not reported) lot # M041394, expiry date: 23-MAY-2018 for prophylaxis. On an unknown date, the patients experienced redness, warmth and discomfort at injection site. The patients were treated with antihistamines: TYLENOL. The outcome of the events was unknown. The reporter did not provide the causality between the events and PNEUMOVAX 23. The reporter had requested lot check for PNEUMOVAX 23. Additional information has been requested.
20 minutes, post vax, started itching on arm, throat and face. Gave Benadryl; told by MD to give Benadryl and call back in 30 minutes. In 30 minutes pt had difficulty breathing, swallowing and nausea. Took her to doctor and he wrote RX for Decadron. Started immediately.